Featured News
![](/sites/default/files/styles/4_3_medium/public/2024/07/02/Doctor-going-through-a-report-with-senior-patient-155317574_6048x4032.jpeg?itok=mlAJ-1MZ)
Press Release
Alzheimer’s Association Statement on European Medicines Agency Negative Opinion on Leqembi for the Treatment of Alzheimer’s Disease
CHICAGO, July 26, 2024 — The Alzheimer’s Association is disappointed by today’s decision by the European Medicines Agency (EMA) to recommend against allowing Leqembi® to be marketed across the Eu...
All News
Press Release
Third Professional Judgment Budget for Alzheimer's Research Funding Released
WASHINGTON, D.C., August 2, 2017 - The National Institutes of Health (NIH) requested in its professional judgement (bypass) budget a...
Press Release
Alzheimer's Research Funding Receives Continued, Strong Bipartisan Support in the House
WASHINGTON, D.C., July 19, 2017 - Today the House Appropriations Committee approved an additional $400 million increase for Alzheimer's and...
Press Release
House Proposes Major Alzheimer's Research Funding Increase to Address Growing Alzheimer's Crisis
WASHINGTON, D.C., July 12, 2017 - Today, the House Appropriations Labor, Health and Human Services, Education and Related Agencies Subcommittee...
Press Release
The Better Care Reconciliation Act
WASHINGTON, D.C., June 23, 2017 - The Alzheimer's Association and Alzheimer's Impact Movement (AIM) are deeply concerned by provisions in...
AIM Blog
Working Together Celebrating Together
Since my wife Denise was diagnosed with Alzheimer's in 2012, I have known the devastation of the disease. Virtually everyday...
AIM Blog
Doubling AIM Membership - How We Did It
Four months ago, we challenged Alzheimer's Impact Movement (AIM) members to multiply their impact by recruiting at least 10 friends...